Haw Par Corporation Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HAWPY research report →
Companywww.hawpar.com
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand.
- CEO
- Ee Lim Wee
- IPO
- 2013
- Employees
- 595
- HQ
- Singapore, SG
Price Chart
Valuation
- Market Cap
- $2.96B
- P/E
- 13.55
- P/S
- 15.64
- P/B
- 0.84
- EV/EBITDA
- 38.80
- Div Yield
- 2.46%
Profitability
- Gross Margin
- 55.99%
- Op Margin
- 29.17%
- Net Margin
- 115.43%
- ROE
- 6.34%
- ROIC
- 1.46%
Growth & Income
- Revenue
- $226.29M · -7.57%
- Net Income
- $261.22M · 14.43%
- EPS
- $4.72 · 14.56%
- Op Income
- $66.02M
- FCF YoY
- 426.27%
Performance & Tape
- 52W High
- $54.44
- 52W Low
- $28.64
- 50D MA
- $53.50
- 200D MA
- $51.29
- Beta
- 0.18
- Avg Volume
- 1
Get TickerSpark's AI analysis on HAWPY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our HAWPY Coverage
We haven't published any research on HAWPY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HAWPY Report →